Shanghai Stock Exchange document szkss (refinancing) [2022] No. 8
— letter of implementation of the opinions of the audit center on Shenzhen Chipscreen Biosciences Co.Ltd(688321) issuing convertible bonds to unspecified objects Shenzhen Chipscreen Biosciences Co.Ltd(688321) . Anxin Securities Co., Ltd.:
In accordance with the relevant provisions of the securities law, the measures for the administration of securities issuance and registration of companies listed on the science and Innovation Board (for Trial Implementation), and the rules for the examination and approval of securities issuance and listing of companies listed on the science and Innovation Board of Shanghai Stock Exchange, the exchange reviewed the application documents of Shenzhen Chipscreen Biosciences Co.Ltd(688321) (hereinafter referred to as the company or issuer) for issuing convertible bonds to unspecified objects. The following issues were discussed at the meeting of the audit center, Please implement:
1、 At present, the project of innovative drug production base (phase III) of the fund-raising project has not obtained the EIA approval yet. The issuer is requested to further explain: (1) the specific progress of the project in obtaining the EIA reply; (2) If it cannot be obtained as scheduled, whether it will have an adverse impact on the implementation process and benefit prediction of relevant raised investment projects.
The recommendation institution is requested to check and express clear opinions.
Please implement the above questions one by one and submit your reply in time. If the reply involves amendments to the prospectus, please indicate it in bold italics. After receiving your reply, we will decide whether to submit it to the Listing Committee for deliberation according to the situation.
Your company is requested to submit the prospectus (draft of the meeting) in time.
Shanghai Stock Exchange
January 13, 2002
Key words: letter of opinions on the implementation of refinancing of science and Innovation Board
Issued by Shanghai Stock Exchange science and Innovation Board listing Audit Center on January 13, 2022
